Cargando…

Diagnosis and Treatment Using Autologous Stem-Cell Transplantation in Primary Central Nervous System Lymphoma: A Systematic Review

SIMPLE SUMMARY: Primary central nervous system (CNS) lymphoma (PCNSL), arising and remaining localized in the CNS, required the development of peculiar therapeutic strategies that deviate from those applied in systemic diffuse large B-cell lymphoma. To date, the optimal treatment approach for PCNSL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Steffanoni, Sara, Calimeri, Teresa, Marktel, Sarah, Nitti, Rosamaria, Foppoli, Marco, Ferreri, Andrés J. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856418/ https://www.ncbi.nlm.nih.gov/pubmed/36672475 http://dx.doi.org/10.3390/cancers15020526

Ejemplares similares

How we treat primary central nervous system lymphoma
por: Calimeri, T., et al.
Publicado: (2021)

International multicenter retrospective analysis of thiotepa-based autologous stem cell transplantation for secondary central nervous system lymphoma
por: Khwaja, Jahanzaib, et al.
Publicado: (2022)

Deep learning-based overall survival prediction model in patients with rare cancer: a case study for primary central nervous system lymphoma
por: She, Ziyu, et al.
Publicado: (2023)

Radiomics-Based Machine Learning Model for Predicting Overall and Progression-Free Survival in Rare Cancer: A Case Study for Primary CNS Lymphoma Patients
por: Destito, Michela, et al.
Publicado: (2023)

Autologous stem cell transplantation for large B-cell lymphoma with secondary central nervous system involvement
por: Akin, Serkan, et al.
Publicado: (2022)

Prevention and management of secondary central nervous system lymphoma
por: Bobillo, Sabela, et al.
Publicado: (2022)

Primary Autologous Stem Cell Transplantation for Unilateral Primary Central Nervous System Lymphoma–Ophthalmic Variant (Primary Vitreoretinal Lymphoma)
por: Lee, Brian, et al.
Publicado: (2023)

Successful Management of Natalizumab-Associated Primary Central Nervous System Lymphoma through Autologous Stem Cell Transplant
por: Moineau-Vallée, Karine, et al.
Publicado: (2020)

Blood Graft and Outcome After Autologous Stem Cell Transplantation in Patients With Primary Central Nervous System Lymphoma
por: Partanen, Anu, et al.
Publicado: (2021)

Autologous Stem Cell Transplantation for Aggressive Lymphomas
por: Visani, Giuseppe, et al.
Publicado: (2012)

Impact of severe acute respiratory syndrome coronavirus‐2 infection on the outcome of primary central nervous system lymphoma treatment: A study of the International PCNSL Collaborative Group
por: Steffanoni, Sara, et al.
Publicado: (2022)

Systemic vs. intrathecal central nervous system prophylaxis in primary adrenal/renal diffuse large b-cell LYMPHOMA: A multi-institution retrospective analysis and systematic review
por: Xie, John, et al.
Publicado: (2021)

Sequential CD19/22 CAR T-cell immunotherapy following autologous stem cell transplantation for central nervous system lymphoma
por: Wu, Jiaying, et al.
Publicado: (2021)

Predictors of central nervous system involvement in diffuse large B-cell lymphoma: a divining rod is wanted
por: Ferreri, Andrés José María
Publicado: (2013)

Thiotepa, Busulfan, Cyclophosphamide: Effective but Toxic Conditioning Regimen Prior to Autologous Hematopoietic Stem Cell Transplantation in Central Nervous System Lymphoma
por: Delphine, Lebon, et al.
Publicado: (2023)

Patient Reported and Clinical Outcomes after High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Primary Central Nervous System Lymphoma
por: Beer, Sina A., et al.
Publicado: (2023)

Second-line treatment for primary central nervous system lymphoma
por: Reni, M, et al.
Publicado: (1999)

Safety and efficacy of a dose-dense short-term therapy in patients with MYC-translocated aggressive lymphoma
por: Ferreri, Andrés J.M., et al.
Publicado: (2022)

Prolonged third complete remission after busulfan, thiotepa, and autologous stem cell transplant in a primary central nervous system lymphoma patient
por: Camus, Vincent, et al.
Publicado: (2018)

ML-12 HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION (HDC-ASCT) FOR THE PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL)
por: Miyakita, Yasuji, et al.
Publicado: (2022)

Impact of Autologous Stem Cell Transplantation on Primary Central Nervous System Lymphoma in First-Line and Relapse Settings: A Retrospective Study in China
por: Liu, Jing, et al.
Publicado: (2023)

Management of central nervous system involvement in multiple myeloma after autologous hematopoietic stem cell transplantation
por: Mousavi-Fatemi, Khatereh, et al.
Publicado: (2020)

High-dose chemotherapy and autologous stem cell transplantation in primary lymphomatoid granulomatosis of the central nervous system
por: Nilius-Eliliwi, Verena, et al.
Publicado: (2022)

Safety and feasibility of outpatient autologous stem cell transplantation in pediatric patients with primary central nervous system tumors
por: Koo, Jane, et al.
Publicado: (2019)

Chimeric antigen receptor T-cell therapy following autologous transplantation for secondary central nervous system lymphoma: A case report
por: Yagi, Yu, et al.
Publicado: (2021)

Targeting the Blood–Brain Tumor Barrier with Tumor Necrosis Factor-α
por: Corti, Angelo, et al.
Publicado: (2022)

Autologous hematopoietic stem cell transplantation in classical Hodgkin's lymphoma
por: Cortez, Afonso José Pereira, et al.
Publicado: (2011)

Isolated central nervous system relapse of multiple myeloma post autologous stem cell transplant- A rare presentation
por: Mittal, Abhenil, et al.
Publicado: (2020)

Efficacy and Safety of Autologous Stem-Cell Transplantation as Part of First-Line Treatment for Newly Diagnosed Primary Central Nervous System Lymphoma: A Systematic Review and Meta-Analysis
por: Liu, Jing, et al.
Publicado: (2022)

The Autologous Hematopoietic Stem Cells Transplantation Combination-Based Chimeric Antigen Receptor T-Cell Therapy Improves Outcomes of Relapsed/Refractory Central Nervous System B-Cell Lymphoma
por: Xue, Fei, et al.
Publicado: (2022)

The Role of Autologous Stem Cell Transplantation in the Treatment of Diffuse Large B-Cell Lymphoma
por: Gunnellini, Marco, et al.
Publicado: (2012)

Aggressive Central Nervous System Relapse after Autologous Stem Cell Transplant in Multiple Myeloma: Case Reports and Literature Review
por: Bergantim, Rui, et al.
Publicado: (2020)

MATRix–RICE therapy and autologous haematopoietic stem-cell transplantation in diffuse large B-cell lymphoma with secondary CNS involvement (MARIETTA): an international, single-arm, phase 2 trial
por: Ferreri, Andrés J M, et al.
Publicado: (2021)

Impact of Autologous and Allogeneic Stem Cell Transplantation in Peripheral T-Cell Lymphomas
por: Reimer, Peter
Publicado: (2010)

Update on the Role of Autologous Hematopoietic Stem Cell Transplantation in Follicular Lymphoma
por: Cabrero, Mónica, et al.
Publicado: (2012)

Autologous stem cell transplant (ASCT) for AIDS-related lymphoma (ARL)
por: Krishnan, A, et al.
Publicado: (2009)

Treatment of Hodgkin Lymphoma Relapsed after Autologous Stem Cell Transplantation
por: Domingo-Domènech, Eva, et al.
Publicado: (2020)

Interleukin-6 as Biomarker for Acute GvHD and Survival After Allogeneic Transplant With Post-transplant Cyclophosphamide
por: Greco, Raffaella, et al.
Publicado: (2019)

R-MPV followed by high-dose chemotherapy with thiotepa-based and autologous stem cell transplantation for newly diagnosed primary central nervous system lymphoma: a single-center experience
por: Lee, Ji Yun, et al.
Publicado: (2021)

Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Young Children with Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System
por: Park, Eun Sil, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_2um2pk8f11a635momu7o2lgpfj